Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Larkin

Showing results (41-50 of 418) with videos related to

Pageof 42
Sort By:
Seminars in Cancer Biology|June 19, 2012
Current and future systemic treatments for renal cell carcinomaRosalie Fisher, Martin Gore, James Larkin
Future Oncology (London, England)|October 6, 2010
Sunitinib for metastatic renal cell carcinomaDeborah Mukherji, James Larkin, Lisa Pickering
Progress in Tumor Research|September 18, 2015
Immunotherapies in Early and Advanced Renal Cell CancerBenjamin Kasenda, James Larkin, Martin Gore
Expert Opinion on Pharmacotherapy|March 31, 2016
Combination dabrafenib and trametinib in the management of advanced melanoma with BRAFV600 mutationsLavinia Spain, Maximilian Julve, James Larkin
Cancer Treatment Reviews|February 15, 2016
Management of toxicities of immune checkpoint inhibitorsLavinia Spain, Stefan Diem, James Larkin
Frontiers in Oncology|June 2, 2012
Inter and intratumour heterogeneity: a barrier to individualized medical therapy in renal cell carcinoma?Rosalie Fisher, James Larkin, Charles Swanton
Future Oncology (London, England)|November 3, 2011
Ipilimumab: showing survival benefit in metastatic melanomaAnna Minchom, Kate Young, James Larkin
British Journal of Cancer|February 18, 2020
New survival standards for advanced melanomaLavinia Spain, James Larkin, Samra Turajlic
Expert Review of Anticancer Therapy|April 21, 2011
Optimizing treatment of metastatic renal cell carcinoma by changing mechanism of actionJames Larkin, Charles Swanton, Lisa Pickering
International Dental Journal|January 4, 2026
Prompt-Driven ChatGPT Carbon Calculator for Dental Practices: Estimation and Tailored Improvement StrategiesBrett Duane, Paul Ashley, James Larkin
Pageof 42

Showing results (41-50 of 418) with videos related to

Sort By:
Pageof 42
Seminars in Cancer Biology|June 19, 2012
Current and future systemic treatments for renal cell carcinomaRosalie Fisher, Martin Gore, James Larkin
Future Oncology (London, England)|October 6, 2010
Sunitinib for metastatic renal cell carcinomaDeborah Mukherji, James Larkin, Lisa Pickering
Progress in Tumor Research|September 18, 2015
Immunotherapies in Early and Advanced Renal Cell CancerBenjamin Kasenda, James Larkin, Martin Gore
Expert Opinion on Pharmacotherapy|March 31, 2016
Combination dabrafenib and trametinib in the management of advanced melanoma with BRAFV600 mutationsLavinia Spain, Maximilian Julve, James Larkin
Cancer Treatment Reviews|February 15, 2016
Management of toxicities of immune checkpoint inhibitorsLavinia Spain, Stefan Diem, James Larkin
Frontiers in Oncology|June 2, 2012
Inter and intratumour heterogeneity: a barrier to individualized medical therapy in renal cell carcinoma?Rosalie Fisher, James Larkin, Charles Swanton
Future Oncology (London, England)|November 3, 2011
Ipilimumab: showing survival benefit in metastatic melanomaAnna Minchom, Kate Young, James Larkin
British Journal of Cancer|February 18, 2020
New survival standards for advanced melanomaLavinia Spain, James Larkin, Samra Turajlic
Expert Review of Anticancer Therapy|April 21, 2011
Optimizing treatment of metastatic renal cell carcinoma by changing mechanism of actionJames Larkin, Charles Swanton, Lisa Pickering
International Dental Journal|January 4, 2026
Prompt-Driven ChatGPT Carbon Calculator for Dental Practices: Estimation and Tailored Improvement StrategiesBrett Duane, Paul Ashley, James Larkin
Pageof 42